Bicara Therapeutics BCAX Common stock, shares issued (in shares)
Common stock, shares issued (in shares) at other companies
Other financials
Where this comes from
Reported directly by Bicara Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:CommonStockSharesIssued.
The official record: Bicara Therapeutics’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about Bicara Therapeutics's common stock, shares issued (in shares).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Bicara Therapeutics's common stock, shares issued (in shares)?
- Bicara Therapeutics (BCAX) reported common stock, shares issued (in shares) of $65.55M in Q1 2026.
- How has Bicara Therapeutics's common stock, shares issued (in shares) changed year-over-year?
- Bicara Therapeutics's common stock, shares issued (in shares) increased by 20.2% year-over-year, from $54.53M to $65.55M.
- What is the long-term trend for Bicara Therapeutics's common stock, shares issued (in shares)?
- Over 2 years (2023 to 2025), Bicara Therapeutics's common stock, shares issued (in shares) has grown at a 791.7% compound annual growth rate (CAGR), from $711.9K to $56.6M.